Pachyonychia Congenita Project
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.pachyonychia.org
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)International Pachyonychia Congenita Research Registry
Recruiting
- Conditions
- Pachyonychia Congenita
- First Posted Date
- 2014-12-22
- Last Posted Date
- 2018-11-21
- Lead Sponsor
- Pachyonychia Congenita Project
- Target Recruit Count
- 2000
- Registration Number
- NCT02321423
- Locations
- 🇺🇸
Pachyonychia Congenita Project, Salt Lake City, Utah, United States
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
Phase 1
Completed
- Conditions
- Pachyonychia Congenita
- Interventions
- Drug: Normal saline (placebo)
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2008-11-19
- Lead Sponsor
- Pachyonychia Congenita Project
- Target Recruit Count
- 1
- Registration Number
- NCT00716014
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
News
No news found